Janux Therapeutics ($JANX) Insider Trading & Smart Money Activity
Janux Therapeutics, Inc. ($JANX) has 14 insider trades and 1 analyst rating on file. Insiders filed 14 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 1
JANX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All JANX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | Truist Securities | Raises to buy | PT $26 | +6.6% | +6.8% | Read | |||||
| Insider | Jake Simson | Buy (Grant or award) | 5.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Jake Simson | Buy (Grant or award) | 15.50K sh | +4.1% | +18.2% | — | |||||
| Insider | L.P. Ra Capital Management | Buy (Grant or award) | 15.50K sh | +4.1% | +18.2% | — | |||||
| Insider | L.P. Ra Capital Management | Buy (Grant or award) | 15.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Winston Kung | Buy (Grant or award) | 15.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Winston Kung | Buy (Grant or award) | 5.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Natasha Hernday | Buy (Grant or award) | 5.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Natasha Hernday | Buy (Grant or award) | 5.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Eric Dobmeier | Buy (Grant or award) | 5.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Eric Dobmeier | Buy (Grant or award) | 5.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Vickie Capps | Buy (Grant or award) | 15.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Vickie Capps | Buy (Grant or award) | 15.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Ronald Barrett | Buy (Grant or award) | 5.50K sh | +4.1% | +18.2% | — | |||||
| Insider | Ronald Barrett | Buy (Grant or award) | 5.50K sh | +4.1% | +18.2% | — |
1W / 1M / 6M = how JANX moved from the trade or filing date.
Insider trading in JANX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Jake Simson | 2 | — | Jun 11, 2026 | ||
| L.P. Ra Capital Management | 2 | — | Jun 11, 2026 | ||
| Winston Kung | 2 | — | Jun 11, 2026 | ||
| Natasha Hernday | 2 | — | Jun 11, 2026 | ||
| Eric Dobmeier | 2 | — | Jun 11, 2026 | ||
| Vickie Capps | 2 | — | Jun 11, 2026 | ||
| Ronald Barrett | 2 | — | Jun 11, 2026 |
Analyst ratings on JANX
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Truist Securities | Raises | buy | $26 | +6.6% | +6.8% | Read |
Frequently asked questions
What is the latest insider trade in JANX?
Jake Simson filed a buy (grant or award) of 5.50K sh on Jun 11, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.